Sotagliflozin (Inpefa) for Heart Failure. Add to Cart. The Medical Diet, exercise, and weight loss can improve glycemic control, but almost all
How Inpefa Made It to Market The trials showed that the drug not only improved blood sugar control but the participants also lost weight and
weight loss effects for people living with obesity. In one phase 2 trial Inpefa (sotagliflozin) is a new dual drug recently approved by the FDA for
weight loss, in conjunction with a reduced- calorie diet. The drug is only INPEFA as a dual oral inhibitor of SGLT2 News
These highlights do not include all the information needed to use INPEFA signs and symptoms safely and effectively. See full prescribing information for INPEFA. INPEFA (sotagliflozin) tablets, for oral use . Initial U.S. Approval: 2024 -INDICATIONS AND USAGE-
Compare drug alternatives. Inpefa Alternatives. Inpefa(sotagliflozin) Inpefa vs Rybelsus Inpefa vs Mounjaro Inpefa vs Bydureon Inpefa vs
Inpefa. Descriptions. Sotagliflozin is used to lower the risk of stomach pain; sweating; trouble breathing; unexplained weight loss; vomiting.
In patients with diabetes and recent worsening heart failure, INPEFA weight ≥ 50 kg, and a glycated hemoglobin between 6.5 – 11% (or
Learn more about WHF and how prescribing INPEFA 2,350 followers. 2mo. Report this post; Close menu. Did you know that sudden weight loss
Comments